Works matching IS 11738804 AND DT 2021 AND VI 35 AND IP 1

Results: 9

Systematic Review and Principal Components Analysis of the Immunogenicity of Adalimumab.

Published in:

BioDrugs, 2021, v. 35, n. 1, p. 35, doi. 10.1007/s40259-020-00458-3

By:

Borrega, Rodrigo;
Araújo, Carlos;
Aguiam, Nádia;
Magro, Fernando;
Fonseca, João Eurico;
Danese, Silvio;
Lopes, João;
Goncalves, Joao

Publication type:

Article

Biosimilar Perceptions Among Healthcare Professionals and Commercial Medical Benefit Policy Analysis in the United States.

Published in:

BioDrugs, 2021, v. 35, n. 1, p. 103, doi. 10.1007/s40259-020-00463-6

By:

Herndon, Kyle;
Braithwaite, Jason;
Berry, Brittany;
Bourget, Kathleen

Publication type:

Article

Administration of CD4+CD25highCD127−FoxP3+ Regulatory T Cells for Relapsing-Remitting Multiple Sclerosis: A Phase 1 Study.

Published in:

BioDrugs, 2021, v. 35, n. 1, p. 47, doi. 10.1007/s40259-020-00462-7

By:

Chwojnicki, Kamil;
Iwaszkiewicz-Grześ, Dorota;
Jankowska, Anna;
Zieliński, Maciej;
Łowiec, Paweł;
Gliwiński, Mateusz;
Grzywińska, Małgorzata;
Kowalczyk, Kamil;
Konarzewska, Aleksandra;
Glasner, Paulina;
Sakowska, Justyna;
Kulczycka, Julia;
Jaźwińska-Curyłło, Anna;
Kubach, Marlena;
Karaszewski, Bartosz;
Nyka, Walenty;
Szurowska, Edyta;
Trzonkowski, Piotr

Publication type:

Article

Emerging Targeted Therapies for Neuromyelitis Optica Spectrum Disorders.

Published in:

BioDrugs, 2021, v. 35, n. 1, p. 7, doi. 10.1007/s40259-020-00460-9

By:

Valencia-Sanchez, Cristina;
Wingerchuk, Dean M.

Publication type:

Article

Effect of Treatment with the PD-1/PD-L1 Inhibitors on Key Health Outcomes of Cancer Patients.

Published in:

BioDrugs, 2021, v. 35, n. 1, p. 61, doi. 10.1007/s40259-020-00459-2

By:

Joung, Kyung-In;
Song, Jong Hwa;
Suh, Kangho;
Lee, Seung-Mi;
Jun, Ji Hyun;
Park, Taehwan;
Suh, Dong Churl

Publication type:

Article

Current and Emerging Targeted Therapies for Acute Graft-Versus-Host Disease.

Published in:

BioDrugs, 2021, v. 35, n. 1, p. 19, doi. 10.1007/s40259-020-00454-7

By:

Kasikis, Stelios;
Etra, Aaron;
Levine, John E.

Publication type:

Article

Budget Impact Analysis of the Introduction of Rituximab and Trastuzumab Intravenous Biosimilars to EU-5 Markets.

Published in:

BioDrugs, 2021, v. 35, n. 1, p. 89, doi. 10.1007/s40259-020-00461-8

By:

Jang, Minyoung;
Simoens, Steven;
Kwon, Taeksang

Publication type:

Article

Payer and Implementation Challenges with Advanced Therapy Medicinal Products (ATMPs).

Published in:

BioDrugs, 2021, v. 35, n. 1, p. 1, doi. 10.1007/s40259-020-00457-4

By:

Spoors, John;
Miners, Alec;
Cairns, John;
Palnoch, Danny;
Summerfield, Ash;
McEntee, Joanne;
Vithlani, Sheena

Publication type:

Article

A Look at the History of Biosimilar Adoption: Characteristics of Early and Late Adopters of Infliximab and Etanercept Biosimilars in Subregions of England, Scotland and Wales - A Mixed Methods Study.

Published in:

BioDrugs, 2021, v. 35, n. 1, p. 75, doi. 10.1007/s40259-020-00456-5

By:

Moorkens, Evelien;
Vulto, Arnold G.;
Kent, James;
McClure, Lindsay;
Boldero, Richard;
Vanhove, Thibault;
Simoens, Steven;
Huys, Isabelle

Publication type:

Article